Zhang et al. confirmed that miR-101 directly targets sex determining region Y related high-mobility group box 9 (SOX9 ) in HCC, suggesting that miR-101 may suppress HCC tumor progression by down-regulating SOX9 (56). The gene discussed is SOX9; the disease is hepatocellular carcinoma.